Germline genetic testing reveals pathogenic variants in uterine serous carcinoma patients
An increase in the risk of developing uterine serous carcinoma (USC) has been observed among BRCA1 and BRCA2 germline pathogenic variant carriers in the published literature. However, routine germline genetic testing is not currently incorporated into USC management guidelines. The primary objective...
Saved in:
Main Authors: | Katelyn Tondo-Steele (Author), Kara J. Milliron (Author), Jean H. Siedel (Author), Shitanshu Uppal (Author), Sofia D. Merajver (Author), Karen McLean (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2024-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Recurrent uterine serous carcinoma with a germline pathogenic BRCA2 variant treated using olaparib: A case report
by: Kayo Inoue, et al.
Published: (2020) -
Patient reported opioid usage following vulvar surgery in gynecologic oncology
by: Katelyn Tondo-Steele, et al.
Published: (2024) -
Germline pathogenic variants associated with ovarian cancer: A historical overview
by: Emma Lund Johansen, et al.
Published: (2022) -
Genomic analyses of germline and somatic variation in high-grade serous ovarian cancer
by: A. W. Adamson, et al.
Published: (2023) -
Germline pathogenic variants in Mexican patients with hereditary triple-negative breast cancer
by: Yanin Chavarri-Guerra, et al.
Published: (2022)